Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.

OBJECTIVE: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronary heart disease (CHD). We evaluated changes in the prevalence of cardiovascular risk factors (CVRFs) and 10-year risk of CHD in a large cohort of HIV-infected individuals. METHODS: All individuals fr...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Glass, T, Ungsedhapand, C, Wolbers, M, Weber, R, Vernazza, P, Rickenbach, M, Furrer, H, Bernasconi, E, Cavassini, M, Hirschel, B, Battegay, M, Bucher, H
Format:	Journal article
Sprache:	English
Veröffentlicht:	2006

Ähnliche Einträge

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
von: Wolbers, M, et al.
Veröffentlicht: (2008)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
von: Wolbers, M, et al.
Veröffentlicht: (2007)

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
von: Fux, C, et al.
Veröffentlicht: (2007)

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
von: Wolbers, M, et al.
Veröffentlicht: (2007)

Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children.
von: Rudin, C, et al.
Veröffentlicht: (2010)

Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
von: Delphine Sculier, et al.
Veröffentlicht: (2017-07-01)

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
von: Hasse, B, et al.
Veröffentlicht: (2014)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy
von: Gasser, O, et al.
Veröffentlicht: (2013)

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
von: Marie Ballif, et al.
Veröffentlicht: (2009-01-01)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
von: Tracy R Glass, et al.
Veröffentlicht: (2012-01-01)

The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
von: Niko Beerenwinkel, et al.
Veröffentlicht: (2013-01-01)

Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study
von: Katharina Kusejko, et al.
Veröffentlicht: (2024-10-01)

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
von: Polesel J, et al.
Veröffentlicht: (2009-06-01)

2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
von: Bucher, H, et al.
Veröffentlicht: (2010)

Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)
von: PA Crisinel, et al.
Veröffentlicht: (2024-09-01)

HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later
von: Pietro Vernazza, et al.
Veröffentlicht: (2016-01-01)

A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.
von: Gran, J, et al.
Veröffentlicht: (2010)

Impact of HIV status on outcome of infectious complications in intravenous drug users.
von: Mertz, D, et al.
Veröffentlicht: (2009)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
von: Helen Kovari, et al.
Veröffentlicht: (2015-01-01)

Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma.
von: Gasser, O, et al.
Veröffentlicht: (2007)

A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa.
von: Frederick Haraka, et al.
Veröffentlicht: (2015-01-01)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
von: Gasser, O, et al.
Veröffentlicht: (2013)

Correction: A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa.
von: Frederick Haraka, et al.
Veröffentlicht: (2015-01-01)

The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
von: Francesca Compagno, et al.
Veröffentlicht: (2019-04-01)

Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
von: Teja Turk, et al.
Veröffentlicht: (2017-09-01)

Parents living with HIV in a high-income country: do patients need specific support?
von: D Gredig, et al.
Veröffentlicht: (2008-01-01)

HIV and solid organ transplantation: The Swiss experience
von: NJ Müller, et al.
Veröffentlicht: (2006-03-01)

Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study.
von: Cleo Gillet, et al.
Veröffentlicht: (2018-01-01)

HIV testing practices by clinical service before and after revised testing guidelines in a Swiss University Hospital.
von: Katharine E A Darling, et al.
Veröffentlicht: (2012-01-01)

Prolonged outpatient parenteral antimicrobial treatment: frequency and evolution over a six-year period in a Swiss University Hospital
von: Munting A., et al.
Veröffentlicht: (2024-11-01)

Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better
von: Katharine EA Darling, et al.
Veröffentlicht: (2016-08-01)

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
von: Katharina Kusejko, et al.
Veröffentlicht: (2020-12-01)

Awareness of HIV testing guidelines is low among Swiss emergency doctors: a survey of five teaching hospitals in French-speaking Switzerland.
von: Katharine E A Darling, et al.
Veröffentlicht: (2013-01-01)

Patients’ understanding of blood tests and attitudes to HIV screening in the emergency department of a Swiss teaching hospital: a cross-sectional observational study
von: Timothée Favre-Bulle, et al.
Veröffentlicht: (2015-11-01)

Prevalence of HIV infection in Turkey and importance of cardiovascular disease
von: Volkan Korten
Veröffentlicht: (2017-03-01)

Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
von: Alexandra U Scherrer, et al.
Veröffentlicht: (2012-01-01)

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
von: Oxenius, A, et al.
Veröffentlicht: (2002)

Disseminated m.avium complex infection in the Swiss HIV cohort study: declining incidence, improved prognosis and discontinuation of maintenance therapy
von: M Rossi, et al.
Veröffentlicht: (2001-08-01)

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
von: Khanna, N, et al.
Veröffentlicht: (2009)

Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial
von: Annalisa Marinosci, et al.
Veröffentlicht: (2024-04-01)